SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sjemmeri who wrote (13091)9/20/2001 4:07:01 PM
From: Bob Rudd  Read Replies (2) of 78652
 
Back in to IVX [Last sold @34] Merrill lowered est to 1.01 & 1.15 after they announced a shipping disruption would hurt generic taxol sales. 16x 02 looks like a thumping discount to the group. Been spectacularly wrong before, but this looks like a good chance for 50+% in a year or so. A key to the story is a shift in the mix from generic to proprietary.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News